Analyst CornerAnalyst Corner—Inside the GLP-1 Boom in the US, with Madhav Pitaliya Madhav Pitaliya, Analyst September 1, 2024 Reasons to ReadWelcome to Analyst Corner! Every Sunday, a member of the Coresight Research team discusses upcoming or recent research and their thoughts on interesting topics in their area of expertise. This week, Madhav Pitaliya, Analyst at Coresight Research, discusses the state of the GLP-1 drug market in the US. Understand key data on obesity rates and recent sales results for weight-loss drugs in this free research report. We also highlight our key research from the past week and reports to look out for in the coming week, so you don’t miss out. Other relevant research: Decoding the GLP-1 Trend: How Is the Ozempic Economy Impacting CPG Retail? What the Ozempic Economy Means for US Retail Data Dive: The Global Obesity Economy—Shaped by the Spending of 1 Billion Consumers Read previous Analyst Corner reports, including last week’s report, which discusses headline data about China’s declining population. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: High Hopes—Heightened Economic Optimism Entering the New Year: US Consumer Survey InsightsKohl’s CEO Removal—Why It Happened and What It Means for US Department StoresWeekly US Store Openings and Closures Tracker 2025, Week 12: Forever 21 To Close All Stores; Dollar General Announces Major Store Expansion PlanShoptalk Fall 2025 Wrap-Up: Driving Retail Forward—AI, Agility, Loyalty and Leadership in Volatile Times
